Differential Dynamics of SARS-CoV-2 Binding and Functional Antibodies upon BNT162b2 Vaccine: A 6-Month Follow-Up

Viruses. 2022 Feb 2;14(2):312. doi: 10.3390/v14020312.

Abstract

To investigate the dynamic association among binding and functional antibodies in health-care-workers receiving two doses of BNT162b2 mRNA COVID-19-vaccine, SARS-CoV-2 anti-RBD IgG, anti-Trimeric-S IgG, and neutralizing antibodies (Nabs) were measured in serum samples collected at 2 weeks, 3 months, and 6 months from full vaccination. Despite the high correlation, results for anti-RBD and anti-Trimeric S IgG were numerically different even after recalculation to BAU/mL following WHO standards indications. Moreover, after a peak response at 2 weeks, anti-RBD IgG levels showed a 4.5 and 13 fold decrease at 3 and 6 months, respectively, while the anti-Trimeric S IgG presented a less pronounced decay of 2.8 and 4.7 fold. Further different dynamics were observed for Nabs titers, resulting comparable at 3 and 6 months from vaccination. We also demonstrated that at NAbs titers ≥40, the area under the receiver operating characteristic curve and the optimal cutoff point decreased with time from vaccination for both anti-RBD and anti-Trimeric S IgG. The mutating relation among the anti-RBD IgG, anti-Trimeric S IgG, and neutralizing antibodies are indicative of antibody maturation upon vaccination. The lack of standardized laboratory procedures is one factor interfering with the definition of a correlate of protection from COVID-19.

Keywords: SARS-CoV-2; anti-Spike IgG; correlates of protection; humoral response; neutralizing antibodies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Neutralizing / blood
  • Antibodies, Neutralizing / immunology
  • Antibodies, Neutralizing / metabolism*
  • Antibodies, Viral / blood
  • Antibodies, Viral / immunology
  • Antibodies, Viral / metabolism*
  • BNT162 Vaccine / administration & dosage
  • BNT162 Vaccine / immunology*
  • Binding Sites, Antibody
  • COVID-19 / immunology*
  • COVID-19 / prevention & control
  • Cohort Studies
  • Female
  • Follow-Up Studies
  • Health Personnel / statistics & numerical data
  • Humans
  • Immunity, Humoral
  • Immunoglobulin G / blood
  • Immunoglobulin G / immunology
  • Immunoglobulin G / metabolism*
  • Kinetics
  • Longitudinal Studies
  • Male
  • Middle Aged
  • SARS-CoV-2 / immunology*
  • SARS-CoV-2 / metabolism*
  • Vaccination

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Immunoglobulin G
  • BNT162 Vaccine